Natural Selection Will Weed Out the Weak in the Race to Autonomous Healthcare
The autonomous healthcare system is about to take shape, and health systems must prepare to…
Natural Selection Will Weed Out the Weak in the Race to Autonomous Healthcare
The autonomous healthcare system is about to take shape, and health systems must prepare to evolve alongside it. The post Natural Selection Will Weed Out the Weak in the Race to Autonomous Healthcare appeared first on MedCity News.
Healthcare AI Beyond the Buzzwords: Ambient, Generative, and Agentic Explained
[Sponsored] The future of healthcare AI is not simply a technology conversation. It is a trust conversation. The post Healthcare AI Beyond the Buzzwords: Ambient, Generative, and Agentic Explained appeared first on MedCity News.
Backed by Threat of Clawbacks, Feds Wield Tight Grip on $50B Rural Health Fund
In Maine, state health officials hoped to steer a slice of $190 million in new federal rural health funding to shield hospitals and clinics from the fallout caused by cuts to federal health programs. Their plan would have helped pay to treat low-income, uninsured patients. But federal leaders overseeing the five-year, $50 billion Rural Health…
Early-Onset Cancers Are on the Rise. Knowing Your Family History Is Crucial.
0:00 0:00 Produced in partnership with: Embed Download Volume Speed 0.5x 1x 1.25x 1.5x 2x Embed this player × <iframe src=”https://kffhealthnews.org/news/healthq-early-onset-cancers-family-history/embed/” width=”600″ height=”200″ frameborder=”0″ scrolling=”no” title=”Early-Onset Cancers Are on the Rise. Knowing Your Family History Is Crucial.”></iframe> Copy Listen in and play along as hosts Cara Anthony and Blake Farmer test their knowledge with a…
Bench to Bedside at AI Speed
How can AI determine who gets matched to new therapies, who is identified for clinical trials, and how patient tracking is scaled across large populations? Chip is joined by Dr. A.J. Blood, a practicing cardiologist at Brigham and Women’s Hospital and the co-founder and Chief Executive Officer of AIwithCare, a startup company that delivers AI-enabled…
Multicare CFO: Decades of CMS Underpayment is Creating an Unfair Two-Tiered System
MultiCare CFO James Lee said decades of government underpayment have pushed U.S. healthcare to a breaking point. He thinks the nation is headed toward a two-tier system — one for patients with commercial coverage, and another for those covered through CMS. The post Multicare CFO: Decades of CMS Underpayment is Creating an Unfair Two-Tiered System…
Elevance Health’s 3 Key Priorities for AI
Elevance Health is leveraging AI for simplifying the member experience, improving the provider experience and making sure employees have the right information at the right time. The post Elevance Health’s 3 Key Priorities for AI appeared first on MedCity News.
Lilly’s Newly Acquired Drug Shows Promise as Next-Gen Blood Cancer Med
Eli Lilly presented encouraging Phase 1 results for AJ1-11095 at the European Hematology Association (EHA) annual meeting in Stockholm. The drug, a type II JAK2 inhibitor in development for myelofibrosis, came from Lilly’s acquisition of biotech startup Ajax Therapeutics. The post Lilly’s Newly Acquired Drug Shows Promise as Next-Gen Blood Cancer Med appeared first on…
From Weight Loss to Lasting Value: The Economic Case for Structured Exercise in GLP-1 Therapy
That is the title of a recent white paper written by myself and Kristy Piccinini alongside a team from the Health and Fitness Association (Greta Wagner, Amy Bantham, Ken Griffin, Richard Beddie, Zach Weston, Cameron Saunders). Below is an excerpt: In recent years, glucagon-like-peptide-1 (GLP-1) receptor agonists have emerged as a transformative treatment option, enabling…
Ellipsis Health
Ellipsis Health has come a long way from its roots in detecting depression via vocal biomarkers. Sage, its charming voice AI agent, is now helping health plans and care management companies directly interact with patients and members, helping them with medication reminders, program recruitment, postop follow up and much more. I spoke with two of…
